Michigan House Bill HB4298

Michigan 2025-2026 Regular Session

• Introduced: 3/25/25
• Refer: 3/25/25

Caption

Health: informed consent; informed consent requirements for breast implant surgery; require. Amends 1978 PA 368 (MCL 333.1101 - 333.25211) by adding secs. 17019 & 17519.

Impact

The bill seeks to ensure that patients are fully informed about the health implications of undergoing breast implant surgery. By requiring that the information be presented during an initial consultation, the legislation emphasizes the importance of patient awareness and safety in medical decisions related to cosmetic procedures. Furthermore, the establishment of an informed consent checklist, which is to be developed by a board in consultation with medical professionals and patient advocacy groups, aims to standardize the information provided to patients, reinforcing transparency in the cosmetic surgery field.

Summary

House Bill 4298 is a legislative initiative aimed at establishing stringent informed consent requirements for breast implant surgeries in Michigan. Set to take effect on January 1, 2026, the bill mandates that physicians must provide patients with comprehensive information regarding the risks associated with breast implants before any surgical procedure. This includes a detailed explanation of the surgery itself, manufacturer information about the implants, and materials to assist patients in understanding the potential adverse effects they may face.

Contention

Notably, the bill addresses serious health concerns linked to breast implants, such as breast implant-associated cancers and illnesses, asserting the necessity for patients to understand these risks. The requirement for physicians to discuss FDA warnings—including potential health complications—reflects an increasing awareness of patient safety in cosmetic surgery. While the bill may receive support from patient advocacy groups and health professionals interested in enhanced safety standards, there could be opposition from the cosmetic surgery industry, which may argue that the increased regulatory burden could complicate compliance and affect surgical practices.